Cas medical systems inc (CASM)
Income statement / Quarterly
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales from continuing operations

-

5,381

5,291

5,444

-

4,526

4,572

4,543

3,608

4,960

4,649

5,455

5,310

4,947

4,707

4,520

2,930

4,729

5,842

5,711

5,944

5,353

5,042

5,575

5,951

6,110

5,198

5,408

5,304

5,785

5,717

5,643

5,801

6,318

Cost of sales

-

2,241

2,110

2,357

-

1,882

2,193

2,061

1,242

2,305

2,051

2,574

2,492

2,469

2,298

2,255

1,211

2,618

3,459

3,367

-

3,920

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,512

3,124

3,350

-

3,596

-

-

-

-

-

-

-

-

Asset impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

407

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,579

3,596

3,015

3,373

3,202

3,590

3,591

3,508

3,407

3,585

Gross profit

3,298

3,140

3,180

3,086

2,753

2,643

2,378

2,482

2,365

2,654

2,597

2,880

2,817

2,478

2,409

2,265

1,718

2,111

2,383

2,343

1,974

1,433

1,918

2,224

2,371

2,514

2,182

2,035

2,102

2,195

2,125

2,134

2,394

2,733

Operating expenses:
Research and development

834

712

833

801

785

803

858

786

684

813

819

955

930

851

898

833

722

849

862

881

1,116

1,012

1,029

1,052

1,273

906

949

890

1,011

996

805

712

476

465

Selling, general and administrative

3,707

3,403

3,473

3,431

3,207

3,133

3,503

3,574

3,517

3,193

3,491

3,367

3,661

3,230

3,321

2,883

2,460

2,730

3,540

3,226

3,951

3,297

3,460

3,081

3,392

3,131

2,897

3,107

2,801

3,039

2,977

2,690

2,751

2,583

Total operating expenses

4,541

4,115

4,306

4,233

3,993

3,937

4,361

4,360

4,201

4,007

4,310

4,323

4,591

4,082

4,220

3,716

3,182

3,579

4,402

4,108

5,068

4,310

4,490

4,134

4,666

4,037

3,846

3,997

3,812

4,035

3,783

3,403

3,228

3,048

Operating loss

-1,243

-975

-1,126

-1,146

-1,239

-1,293

-1,983

-1,878

-1,836

-1,352

-1,713

-1,442

-1,774

-1,604

-1,810

-1,451

-1,463

-1,468

-2,018

-1,764

-3,094

-2,877

-2,572

-1,909

-2,295

-1,522

-1,664

-1,962

-1,710

-1,840

-1,657

-1,268

-834

-315

Interest expense, net

301

307

589

271

277

274

264

259

262

264

322

199

210

216

214

217

220

226

255

85

86

86

76

65

66

46

0

0

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

8

26

2

4

3

0

0

0

0

16

0

0

0

3

15

388

2

4

15

16

12

8

2

2

-10

-22

Loss from continuing operations before income taxes

-1,544

-1,283

-1,715

-1,417

-1,516

-1,567

-2,248

-2,138

-2,089

-1,589

-2,033

-1,637

-1,981

-1,820

-2,024

-1,669

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,677

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,697

-1,831

-1,654

-1,266

-844

-338

Income tax benefit

-

0

0

0

37

-1,629

-49

-103

-144

-84

-103

-1,091

-66

-67

-15

-58

-

0

-

-

-

-

-

-

-

-

-

-

-5

8

-107

-20

-128

-146

Loss from continuing operations

-1,544

-1,283

-1,715

-1,417

-1,553

61

-2,198

-2,035

-1,945

-1,505

-1,929

-545

-5,135

-1,753

-2,008

1,610

-

-1,677

-

-

-

-

-

-

-

-

-

-

-1,692

-1,839

-1,547

-1,245

-715

-192

Discontinued operations:
Income from discontinued operations

-

0

0

0

40

268

142

294

564

240

296

175

215

193

61

151

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of discontinued operations

-

0

-

-

-

4,388

-

-

-31

0

0

2,942

-24

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

-

0

0

0

-37

1,629

49

103

144

84

103

1,091

66

67

15

58

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations

-

0

0

0

77

3,026

92

191

388

156

192

2,026

124

125

46

92

-

-

-

-

-

-

-

-

-

-

-

-

10

-15

207

39

207

199

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-1,544

-1,283

-1,715

-1,417

-1,476

3,088

-2,105

-1,843

-1,556

-1,349

-1,736

1,480

-1,790

-1,627

-1,962

-1,518

-1,791

-1,687

-2,274

-1,849

-3,181

-2,960

-2,633

-1,587

-2,147

-1,564

-1,649

-1,946

-1,681

-1,855

-1,340

-1,205

-508

7

Preferred stock dividend accretion

436

429

422

414

407

400

393

387

380

373

367

361

354

348

342

336

331

325

319

314

308

303

298

293

288

283

278

273

-

288

74

-

-

-

Net loss applicable to common stockholders

-1,981

-1,712

-2,137

-1,832

-1,884

2,687

-2,499

-2,230

-1,936

-1,723

-2,103

1,119

-2,145

-1,976

-2,305

-1,855

-2,122

-2,012

-2,593

-2,163

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,263

-2,932

-1,880

-

-1,847

-1,927

-2,219

-

-2,143

-1,414

-1,205

-508

7

Loss per common share from continuing operations - basic and diluted

-0.07

-0.06

-0.08

-0.07

-0.08

-0.01

-0.09

-0.09

-0.09

-0.07

-0.09

-0.03

-0.08

-0.08

-0.09

-0.09

-

-0.10

-

-

-

-0.19

-0.22

-0.14

-

-0.14

-0.15

-0.17

-0.15

-0.16

-0.12

-0.10

-0.06

-0.02

Income per common share from discontinued operations: basic and diluted

-

0.00

0.00

0.00

0.01

0.11

0.00

0.01

0.02

0.01

0.01

0.07

0.00

0.01

0.00

0.01

-

0.00

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.01

0.01

0.02

0.02

Per share basic and diluted loss applicable to common stockholders

-0.07

-0.06

-0.08

-0.07

-0.07

0.10

-0.09

-0.08

-0.07

-0.06

-0.08

0.04

-0.08

-0.07

-0.09

-0.08

-0.12

-0.10

-0.13

-0.11

-

-

-

-

-

-

-

-

-0.15

-0.16

-0.11

-0.09

-0.04

0.00

Weighted-average number of common shares outstanding: Basic and diluted

27,883

27,833

27,750

27,611

27,351

27,335

27,329

27,025

26,849

26,833

26,823

26,800

26,760

26,643

26,595

22,804

19,280

19,283

19,226

19,148

18,798

17,471

13,425

13,391

13,353

13,313

13,260

13,218

13,174

13,144

13,086

13,011

12,808

11,617